About VIRIS Detection Systems
VIRIS Detection Systems is a company based in Denver (United States) founded in 2020 by Blake Wiedenheft. VIRIS Detection Systems operates in a competitive market with competitors including Guardant Health, Natera, Denali Therapeutics, Foundation Medicine and ArcherDX, among others.
- Headquarter Denver, United States
- Founders Blake Wiedenheft
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of VIRIS Detection Systems
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Seed - VIRIS Detection Systems | Valuation | Khosla Ventures |
|
Investors in VIRIS Detection Systems
VIRIS Detection Systems has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Khosla Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location |
Investments & Acquisitions by VIRIS Detection Systems
Financial Statements - VIRIS Detection Systems
Viris Detection Systems Comparisons
Competitors of VIRIS Detection Systems
VIRIS Detection Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Denali Therapeutics, Foundation Medicine and ArcherDX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
Latest news on Viris Detection Systems
Frequently Asked Questions about VIRIS Detection Systems
VIRIS Detection Systems was founded in 2020.
VIRIS Detection Systems is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Blake Wiedenheft is the current CEO of VIRIS Detection Systems. They have also founded this company.
VIRIS Detection Systems was founded in 2020 in Denver, United States, within the biotechnology sector. Operations center on the creation of CRISPR-based RNA-guided diagnostic tools. A primary focus is placed on rapid tests for detecting SARS-CoV-2. Development efforts emphasize precision and speed in viral identification, supporting healthcare applications across the region.
VIRIS Detection Systems's top competitors include Guardant Health, Juno Therapeutics and Foundation Medicine.
VIRIS Detection Systems has 1 investor. Key investors include Khosla Ventures.